Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients

Summary

The CXCR4/CXCR7/CXCL12 chemokine axis plays important roles in the migration of tumor cells during cancer development by modulating site-specific distant metastasis including to regional lymph nodes. We investigated the correlation of these chemokine expressions to prognosis in lymph-node-positive non-small-cell lung cancer (NSCLC) patients. A total of 140 surgically resected specimens of primary site (PS) and metastatic lymph nodes (MLN) of NSCLC involving hilar and/or mediastinal lymph nodes (N1–2) were collected. CXCR4, CXCR7 and CXCL12 expressions were evaluated. Cox regression analysis was performed to determine whether these chemokines were independent prognostic factors in N1–2 NSCLC. High expression of CXCR4 in PS and CXCL12 in MLN was associated with poor overall survival (OS) (p = 0.025 and 0.033, respectively). Significant correlations between CXCR4 expression in PS and CXCL12 expression in MLN were observed (p = 0.040). There was significant difference in OS between two groups according to expressions of CXCR4 in PS and CXCL12 in MLN (p = 0.0033). Expression of CXCL12 in MLN was identified as an independent prognostic factor (HR 1.79, 95% CI 1.08–3.04, p = 0.023). CXCL12 in MLN was mainly expressed by tumor cells compared with stromal cells (56% vs. 25%, respectively, p < 0.0001). CXCR4/CXCL12 may play roles in tumor progression in MLN and is associated with poor prognosis of lymph-node-positive NSCLC patients.

This article is protected by copyright. All rights reserved.

http://ift.tt/2gkygbD